Canadian Manufacturing

Cdn. government announces investment in biomanufacturing facility in B.C.

by CM Staff   

Manufacturing Financing Operations Regulation Research & Development Supply Chain Public Sector biomanufacturing financing Government healthcare In Focus Manufacturing medicine Pharmaceutical Manufacturing


This investment has contributed to the construction of a brand new good manufacturing practices (GMP) biomanufacturing facility where STEMCELL Technologies can now manufacture products at a higher regulatory compliance standard.

BURNABY — The Government of Canada is investing in a life sciences ecosystem capable of responding to current and future health emergencies.

On Jul. 9, François-Philippe Champagne, Minister of Innovation, Science and Industry, announced the opening of STEMCELL Technologies‘ facility, in Burnaby, British Columbia, which has been supported through a $22.5 million investment by the Government of Canada, matched by the Government of British Columbia. This investment has contributed to the construction of a brand new good manufacturing practices (GMP) biomanufacturing facility where STEMCELL Technologies can now manufacture products at the higher regulatory compliance standard required to support clinical trials for cell therapy, tissue engineering, immunotherapy, gene therapy and regenerative medicine, with the ultimate aim of curing cancer and other serious diseases. With the completion of this project, STEMCELL Technologies created more than 1,000 new full-time jobs in British Columbia, far exceeding the project’s target of 675.

The expansion of STEMCELL Technologies’ presence in British Columbia strengthens the province’s status as a biomanufacturing and life sciences hub and will generate more research and development (R&D) and more collaboration with academia. It will also ensure new intellectual property being developed remains in Canada.

“Our government is committed to supporting innovation in the life sciences sector to ensure Canadians have access to the most cutting-edge medical technologies to keep them safe. The opening of STEMCELL Technologies’ state-of-the-art facility is another important milestone in achieving a robust domestic life sciences sector in Canada. Through investments such as this, we are securing domestic supply chains and ensuring new intellectual property remains in Canada, while supporting the creation of hundreds of great-paying jobs for Canadian workers,” said François-Philippe Champagne, Minister of Innovation, Science and Industry.

“Supporting research and development expansion, as well as job growth in diverse and dynamic fields, all across Canada is essential to creating stronger local economies. Leaps in progress often happen because of many smaller steps, on many roads leading to the same destination,” said Terry Beech, Minister of Citizens’ Services.

Advertisement

Stories continue below